Alsin, the founder of investment firm Worm Capital, had an abundance of classic Asperger’s symptoms. He was sensitive to light and sound and was so anxious around people that he forswore becoming a ...
The AI news for June 28-29, 2026, despite being the weekend, featured themes that symbolize the current state of the AI industry: a backlash against over-reliance on AI, alongside the simultaneous ...
🚑 Remix Therapeutics, a Watertown, Mass.-based RNA processing reprogramming biotech, is going public via a reverse merger with Passage Bio (Nasdaq: PASG). Remix has raised over $200m from firms like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results